Related Experiment Video
Updated: Aug 14, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiac assist devices: present status and future opportunities
1Hospital Henri Mondor, Service de Chirurgie Thoracique et Cardiovasculaire, 51 avenue du Marechal de Lattre de Tassigny, 94010 Creteil Cedex, France. loisance@univ-paris12.fr
Expert Review of Medical Devices
|November 19, 2005
Summary
Mechanical circulatory support systems have advanced significantly over 20 years, showing efficacy in severe cardiac failure patients. This progress allows for assessing current devices and predicting future developments in cardiac support technology.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Technology
Background:
- Severe cardiac failure necessitates advanced treatment options.
- Mechanical circulatory support (MCS) has emerged as a critical therapy.
- Significant technological and clinical advancements have occurred in MCS over two decades.
Purpose of the Study:
- To review the progress in MCS technology and clinical applications.
- To assess the efficacy of state-of-the-art MCS devices in selected patient groups.
- To predict future developments in the field of mechanical circulatory support.
Main Methods:
- Review of technological advancements in MCS.
- Analysis of clinical data from pioneering centers using MCS.
- Assessment of current MCS devices and their performance.
Main Results:
- Continuous progress in MCS technology and clinical use over the past 20 years.
- Demonstrated efficacy of MCS in selected patients with severe cardiac failure.
- Established a basis for evaluating current devices and future trends.
Conclusions:
- MCS technology has matured significantly, offering viable solutions for severe heart failure.
- Experience in pioneering centers highlights the effectiveness of current MCS devices.
- Future developments are anticipated to further enhance MCS capabilities and patient outcomes.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...